Source dissolve lip filler liporase for Lips, Nose, and Cheeks

Strategic Sourcing Guide for Liporase and Hyaluronic Acid Dissolvers

The procurement landscape for enzymatic solutions designed to reverse hyaluronic acid (HA) fillers requires a rigorous, evidence-based approach. Buyers focusing on the core keyword "dissolve lip filler liporase" must navigate a market where product attributes vary significantly between listings. The available data indicates a diverse range of specifications, from 10-vial boxes to specific unit counts like 1500 IU, originating from both South Korea and China. This guide synthesizes observed product facts and trusted category knowledge to assist procurement professionals in evaluating suppliers, verifying technical compliance, and establishing a reliable supply chain for these critical medical supplies.

Technical Specifications and Product Variability

A primary challenge in sourcing Liporase and similar hyaluronidase products is the inconsistency in listed specifications. The observed product data reveals multiple distinct configurations that buyers must distinguish before placing orders. One common configuration lists the product model as "10vials" with a standard of "10vials/box," while another specifies a potency of "1500 lU* 10 vails" or "1500IU*10 vails." These numerical discrepancies are not merely formatting errors; they represent different dosing strengths and packaging units that directly impact clinical application and inventory management.

The physical form of the product is another critical variable. While some listings describe the product as a powder, others imply a liquid state suitable for injection. The "Ways to Use" attribute consistently identifies the product as "Injectable," confirming its intended route of administration. However, the storage requirements vary between "2 ºC~25 ºC" and "Room Temperature." This divergence necessitates a strict verification process with the supplier to ensure the product's stability during transit and storage. If a buyer intends to store the product at room temperature, they must confirm that the specific batch they are purchasing does not require refrigeration, as deviations can compromise the enzymatic activity of the hyaluronidase.

Furthermore, the color of the product is listed as both "Transparent" and "White" across different entries. This observation suggests that the appearance may depend on the concentration, the solvent used, or the specific manufacturing batch. Procurement teams should not rely on color as a definitive quality indicator but rather as a variable to be documented during the receiving inspection. The packaging is generally described as a "Strong Packaging Box" or "10vial/Box," which aligns with the need for secure transport of medical supplies.

Compliance, Certification, and Regulatory Standards

In the medical device and pharmaceutical sector, certification is the primary gatekeeper for supplier eligibility. The observed data presents a wide spectrum of claimed certifications, ranging from "CE" alone to comprehensive lists including "CE, ISO, RoHS, CCC, QS, FDA." While the presence of CE marking is a baseline requirement for many markets, the inclusion of FDA, ISO, and other standards indicates a higher level of regulatory adherence. However, buyers must treat these claims as observations that require independent verification rather than absolute guarantees.

The origin of the product is a significant factor in regulatory compliance. Listings indicate origins in both "South Korea" and "China." South Korea has a robust reputation in the cosmetic and medical device industry, often associated with stringent quality control measures. Conversely, products originating from China may have different regulatory pathways depending on the specific manufacturing facility and the target export market. The "Type" of product is consistently identified as "Surgical Supplies Materials," which places it under specific regulatory frameworks that vary by jurisdiction.

Buyers must verify that the supplier can provide valid, up-to-date certificates of analysis (CoA) and certificates of conformity (CoC) that match the specific product model and batch number. The claim of "Without Ethylene Oxide Sterilization" is a notable attribute found in some listings. This is critical for buyers concerned about residual sterilization agents, as ethylene oxide is a known carcinogen. If a buyer requires ethylene oxide-free products, they must explicitly confirm this attribute with the supplier, as the absence of this sterilization method may imply the use of alternative techniques like gamma irradiation or filtration, which have their own validation requirements.

Cost Drivers and Pricing Dynamics

The pricing for Liporase and HA dissolvers is influenced by several factors, including potency, packaging, and regulatory status. The observed price range in the market is between 3 and 50 USD. This wide variance suggests that the lower end of the spectrum may represent bulk pricing, single-unit costs, or products with different potency levels (e.g., 1500 IU vs. other concentrations). The higher end likely reflects premium packaging, specific certifications, or smaller order quantities.

The Minimum Order Quantity (MOQ) is another significant cost driver. The data shows an MOQ range of 1 to 20 units. A low MOQ of 1 allows for trial orders and reduces inventory risk for new buyers, while an MOQ of 20 may be necessary to achieve the lower price points per unit. Buyers should calculate the total cost of ownership, including shipping and potential customs duties, rather than focusing solely on the unit price. The "Delivery Time" is listed as 3-7 days for some suppliers, which is a competitive advantage for urgent medical needs, but this lead time must be confirmed for every transaction, as it can fluctuate based on stock availability and logistics.

Stock levels also play a role in pricing stability. One listing mentions a stock of 5000 units, indicating a supplier with significant inventory capacity. High stock levels can prevent supply chain disruptions but may also indicate older batches if not managed correctly. Buyers should inquire about the "Quality Guarantee Period," which is listed as "Two Years" or "2years" in the data. This shelf life is a crucial factor in determining the economic viability of purchasing in bulk.

Typical Applications and Clinical Scope

The functional scope of Liporase and similar hyaluronidase products is extensive, targeting the removal of hyaluronic acid-based fillers. The "Function" attributes consistently highlight the ability to "Dissolve Hyaluronic Acid," "Remove Fillers," and "Remove The Body Remaining Hayluronic Acid." Specific application areas listed include the "Lips, Jawline, Nose, Cheek, Chin, Nasolabial," and in some broader claims, the "Face, Lip, Nose, Cheek, Chin, Breast, Buttock etc."

It is essential for buyers to understand that while the product is designed to dissolve HA fillers, the efficacy can vary based on the location and type of filler used. The "Usage" is specified as "Injection" and "Skin Care," indicating its dual role in corrective procedures and general dermatological treatments. The target demographic is clearly defined as "Adult," and the product is intended for professional use by medical practitioners.

The "Efficacy" is described as "Dissolves Ha Dermal Fillers," which confirms the mechanism of action. However, buyers should not assume that the product is effective for all types of dermal fillers, as non-hyaluronic acid fillers (such as calcium hydroxylapatite or poly-L-lactic acid) require different dissolution methods. The "Customization" attribute being "Available" suggests that some suppliers may offer tailored packaging or labeling, which can be valuable for clinics operating under specific branding requirements.

Supplier Evaluation and Quality Assurance

Evaluating suppliers for medical-grade enzymatic products requires a multi-faceted approach. The "Pharmaceutical Technology" used is listed as "Chemical Synthesis," which is the standard method for producing hyaluronidase. Buyers should verify the supplier's adherence to Good Manufacturing Practices (GMP) and their ability to provide batch-specific testing results. The "Logo Printing" attribute is noted as "Without Logo Printing" in some cases, indicating that some suppliers offer generic packaging, while others may support private labeling.

Quality control should extend beyond the initial purchase. The "Self" attribute, likely referring to the shelf life or self-storage capability, is listed as "2years." This aligns with the "Shelf Life" attribute of "2 Years." Buyers must implement a first-expiry-first-out (FEFO) inventory management system to ensure that older stock is used before newer batches. The "Group" attribute specifies "Adult," reinforcing the need for age-appropriate usage protocols.

When selecting a supplier, buyers should prioritize those with transparent communication regarding the "prod_packing" and "prod_model." The consistency between the ordered model and the delivered product is paramount. Discrepancies in model numbers, such as "10vials" versus "1500 lU* 10 vails," can lead to clinical errors. Therefore, a clear purchase order that explicitly states the required potency, packaging, and origin is essential.

Long-Term Procurement Considerations

Sourcing Liporase and HA dissolvers is not a one-time transaction but a long-term relationship that requires ongoing monitoring. The "Lead Time" of 3-7 days is attractive, but buyers must consider the potential for delays due to regulatory changes or supply chain disruptions. Establishing a relationship with a supplier who has a "Stock" of 5000 units can provide a buffer against shortages, but it is also important to maintain a diversified supplier base to mitigate risk.

The "Certification" landscape is dynamic, with standards like CE, ISO, and FDA potentially undergoing updates. Buyers should schedule regular audits or reviews of their suppliers' certification status to ensure continued compliance. The "Standard" of "1500u" or "10*10ml" should be clearly defined in the contract to avoid ambiguity. Additionally, the "Storage" requirements must be strictly adhered to throughout the supply chain, from the manufacturer to the end-user.

Finally, buyers should consider the "Customization" options available. If a clinic requires specific branding or packaging, the "Available" customization attribute offers a strategic advantage. However, this must be balanced against the potential for increased lead times or costs. By maintaining a disciplined approach to specification verification, certification checks, and quality control, procurement professionals can ensure a steady supply of high-quality Liporase and HA dissolvers for their medical practices.

In conclusion, the procurement of Liporase and hyaluronic acid dissolvers demands a high degree of diligence. By focusing on the specific technical attributes, verifying certifications, and understanding the cost drivers, buyers can navigate the complexities of this market. The observed data provides a foundation for inquiry, but the ultimate responsibility lies with the buyer to validate every claim through direct communication with the supplier and independent quality assurance processes.